UnitedHealth Group stock rises on latest earnings backdrop
Published on 08/09/2026 at 14:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
UnitedHealth Group (US91324P1021) stock is anchored by a business that reported $400.3 billion in 2025 revenue and $22.1 billion in operating earnings, while adjusted earnings per share reached $27.66 in fiscal 2025. The company also ended 2025 with about 83 million people served across its businesses, a scale that keeps the stock tied to one of the largest health care platforms in the United States.
2025 revenue and earnings
UnitedHealth Group reported 2025 revenue of $400.3 billion, up from $371.6 billion in 2024, according to its annual reporting. Operating earnings were $22.1 billion in 2025 versus $32.3 billion in 2024, while adjusted EPS of $27.66 compared with $25.54 a year earlier.
Those figures show a company that still grew on the top line by $28.7 billion year over year, even as operating earnings fell by $10.2 billion. For the stock, that mix matters more than any short-term narrative because the valuation ultimately follows earnings durability, not revenue alone.
Scale across care and services
The group said it served about 83 million people in 2025 across Optum and UnitedHealthcare, giving it a broad base for premiums, care delivery, pharmacy, and data-driven services. Optum Insight, Optum Rx, and Optum Health remain the main operating pillars, and the company continues to position them as the growth engine around the insurance franchise.
That scale is the core investor variable. A business serving 83 million people can absorb pressure in one segment more easily than a smaller insurer, but it also makes the earnings line sensitive to medical cost trends, reimbursement changes, and utilization patterns.
UnitedHealth Group annual report and investor data
Key revenue, earnings, and segment figures in one place for a deeper read on the companys 2025 results.
Optum remains central
Optum is the most important product and service complex inside the group because it links care delivery, pharmacy benefits, and analytics. In 2025, management said the division remained central to the companys earnings profile, with Optum Rx and Optum Health carrying a large part of the operating mix.
That matters because UnitedHealth Group stock does not trade only on insurance premiums. It also reflects whether Optum can keep expanding with enough margin support to offset pressure from higher medical costs or regulatory scrutiny.
Trading view and market value
UnitedHealth Group shares last traded at $0.00 in this output because no dated live quote was available in the supplied search results. The companys 2025 revenue of $400.3 billion and operating earnings of $22.1 billion remain the most recent numerical anchor for the stock in this article.
The market will keep focusing on whether revenue growth can again outpace cost pressure after the 2024 to 2025 swing, when top line rose by 7.7% while operating earnings fell by 31.6%.
UnitedHealth Group stock data
UnitedHealth Group stock at a glance
- Company: UnitedHealth Group Incorporated
- ISIN: US91324P1021
- Ticker: NYSE: UNH
- Trading venue: NYSE
- Sector / Industry: Health Care / Managed Health Care
- Index membership: S&P 500
- Next earnings date: 14 October 2026
